Sintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>SO-PNP refers to a specialized phosphorus-based ligand, typically <strong>Sulfonated 2-Diphenylphosphino-N-phenylamine</strong>, synthesized via sulfonation of PNP precursors. Its core process involves electrophilic aromatic substitution followed by phosphination. Molecular formula: <strong>C18H15NO4PS</strong>; CAS No: <strong>Not publicly listed</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Catalysis:</strong> Used as a chiral ligand in asymmetric hydrogenation and cross-coupling reactions.</li>
<li><strong>Pharmaceuticals:</strong> Facilitates synthesis of complex active pharmaceutical ingredients (APIs).</li>
<li><strong>Agriculture:</strong> Employed in developing high-efficiency agrochemical intermediates.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Storage:</strong> Keep under inert atmosphere at -20°C to prevent oxidation.</li>
<li><strong>Safety:</strong> Requires PPE due to potential skin irritation and toxicity.</li>
<li><strong>Regulatory:</strong> Not for direct clinical use; strictly industrial intermediate only.</li>
</ul>